Dr. Devavrat Arya

• TRAINED AT: General Medicine from Gujarat University
• ORGAN SPECIALIZATION:

  Speciality Interest

  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Bone and Soft Tissue Sarcomas
  • 
    
• PUBLICATIONS: • Molecular Markers as prognostic factors and response to anthracycline based chemotherapy in Locally Advanced Breast cancer as thesis for D.M. (Medical Oncology), accepted by Gujarat University in 2011
  .• Presented the paper (poster session) “Molecular Markers including S VEGF as predictive factors in response to anthracycline based neo adjuvant chemotherapy in patients with Locally Advanced Breast Cancer” at the IMPAKT breast cancer conference in Belgium in May 2012.

  • Poster presentation: “The cost of treatment of AML: An Indian experience” at the ESMO congress, Vienna, September 2012

  .• Accepted for publication in abstract book - “Molecular Markers as prognostic factors and response to anthracycline based chemotherapy in patients with Locally Advanced Breast Cancer – Experiences from a developing nation” in ESMO congress, Vienna, September 2012.

  • EGFR TKI Erlotinib in Patients with Advanced Squamous Cell Carcinoma of the Lung: A Retrospective Analysis from India Devavrat Arya, September 2015Volume 10, Issue 9, Supplement 2, Pages S761–S790

  • Addition of docetaxel or abiraterone to androgen deprivation therapy in metastatic castration-naive prostate cancer in South Asian population: ASCO 2019, co - author

  T.• Prevalence of germline BRCA1 and BRCA2 mutations and variants among ovarian, primary peritoneal and fallopian tube cancer patients: A multicentre Indian study : Poster at ESMO 2019, co -author
• REGISTRATION: Medical Council, No. DMC/R/00789
• EDUCATION:
  • MBBS from Maulana Azad Medical College, Delhi University
  • M.D. (Internal Medicine) from Govt. Medical College, Surat, (South Gujarat University)
  • D.M. (Medical Oncology) from Gujarat Cancer & Research Institute, B J Medical College, Ahmedabad, (Gujarat University)